← Back to Search

Selective Estrogen Receptor Modulator

Obese males with hypogonadism-active for Hypogonadotropic Hypogonadism

Phase 2
Waitlist Available
Led By sandeep dhindsa, md
Research Sponsored by Sandeep Singh Dhindsa, M.D., F.A.C.E
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 weeks

Summary

This trial will study the effects of low testosterone in young men who are obese, and the result of treating them with clomiphene.

Eligible Conditions
  • Hypogonadotropic Hypogonadism

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Serum Free Testosterone
Secondary study objectives
change in inhibin B
change in insulin like factor 3
change in insulin resistance (HOMA-IR)
+1 more

Trial Design

4Treatment groups
Active Control
Placebo Group
Group I: Obese males with hypogonadism-activeActive Control1 Intervention
Subjects will be randomized to receive clomiphene capsules
Group II: Obese males with normal testosteroneActive Control1 Intervention
comparison group
Group III: lean males with normal testosteroneActive Control1 Intervention
comparison group
Group IV: Obese males with hypogonadism-placeboPlacebo Group1 Intervention
Subjects will be randomized to receive placebo capsules

Find a Location

Who is running the clinical trial?

Sandeep Singh Dhindsa, M.D., F.A.C.ELead Sponsor
sandeep dhindsa, mdPrincipal InvestigatorSt. Louis University
~1 spots leftby Dec 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top